Pomegranate Extract
Best-in-class: Pomegranate Extract
A polyphenol extract for blood flow, blood pressure and antioxidant support — and the dietary source your gut turns into Urolithin A.
Pomegranate Extract quick facts
| Suggested dose | Standardized to punicalagins/ellagic acid, as directed. |
| How often | Daily |
| Who it's for | Cardiovascular, blood-flow and antioxidant support. |
The critical caveat is conversion: roughly 40% of people lack the gut bacteria to produce Urolithin A from pomegranate at all, so a substantial minority get none of the mitochondrial benefit no matter how much they take. If that is the effect you want, supplementing the metabolite directly is the reliable route. A small trial showed reduced carotid intima-media thickness, which is a structural endpoint worth respecting.
How Pomegranate Extract actually works
Punicalagins and ellagitannins are metabolized by gut bacteria into urolithins — and Urolithin A is the mitophagy-inducing compound with its own trial base. Pomegranate also improves nitric oxide bioavailability and has direct antioxidant activity on LDL particles.
Where to get Pomegranate Extract
Find Pomegranate Extract on iHerb →The evidence for Pomegranate Extract
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show improved blood pressure, endothelial function and reduced arterial plaque markers.
- The precursor to Urolithin A (mitophagy).
📊 Correlative data
- Higher pomegranate-polyphenol intake tracks with cardiovascular benefit.
🧪 Theoretical / extrapolated benefits
- Punicalagins are predicted to act largely through conversion by gut bacteria to urolithin A, which induces mitophagy. That predicts substantial non-response: only a minority of people carry the bacteria to make the conversion efficiently, which is precisely why direct urolithin A products exist.
- Also predicted to improve endothelial function through nitric oxide, and to inhibit ACE — the blood pressure route.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Pomegranate Extract actually does
The molecule on the label is too big to be the molecule that acts. Punicalagin is an ellagitannin with a molecular weight above 1,000 and more than fifteen free phenolic hydroxyls. Nothing that size and that polar crosses an enterocyte in meaningful quantity. What happens instead is hydrolysis in the gut lumen to ellagic acid, and then a colonic bacterial conversion of ellagic acid to the urolithins — small dibenzopyranone metabolites that are absorbed, conjugated and circulate for a day or more. The compound that reaches your artery is made by your bacteria out of a precursor, and it is not the compound the bottle is standardized to.
And your bacteria may not make it. That is the fact this page is built on. Human ellagitannin metabolism sorts into three stable phenotypes: metabotype A, producing urolithin A only; metabotype B, additionally producing isourolithin A and urolithin B; and metabotype 0, producing no urolithins at all. Those phenotypes were observed consistently across intervention trials, independently of food source, age and health status Tomas-Barberan 2014. This is not a quantitative variation in absorption of the kind every polyphenol has. It is a categorical, stable, personal trait that determines whether the proposed active metabolite exists in you at all.
The named enzyme target, with a number. In hypertensive patients, two weeks of 50 mL of pomegranate juice per day — delivering 1.5 mmol of total polyphenols — produced a 36% decrement in serum angiotensin-converting-enzyme activity and a 5% reduction in systolic blood pressure; a dose-dependent 31% inhibition of serum ACE was reproduced in vitro Aviram 2001. ACE is the peptidase that converts angiotensin I to angiotensin II and degrades bradykinin; it is the target of every drug ending in -pril. A botanical with a 36% inhibition of the same enzyme is making a real pharmacological claim, and it is the reason the blood-pressure endpoint on this page has a mechanism behind it rather than a vibe.
The second arm is oxidation, and it is a different claim. The long carotid study reported reduced LDL oxidation alongside its imaging and pressure results Aviram 2004, and the program behind it attributes that to preservation of paraoxonase-1 activity on the HDL particle. Note what that predicts: a change in how LDL behaves rather than in how much of it there is. Ordinary LDL-C is the wrong marker for it.
Cell, rodent, human — and where it stops
In cells. LDL oxidation assays and macrophage cholesterol handling, plus direct inhibition of serum ACE in vitro at 31% Aviram 2001.
In people, small and fast. Hypertensive patients, 50 mL of juice daily for two weeks, ACE activity down 36% and systolic pressure down 5% Aviram 2001. That is a two-week study with a biochemical endpoint and it is the mechanistic anchor for everything after it.
In people, long and imaging-based — and then the replication. Patients with carotid artery stenosis drank pomegranate juice for three years, with common carotid intima-media thickness, blood pressure and LDL oxidation all reported as reduced Aviram 2004. Then a larger, longer, independently run trial gave 240 mL of pomegranate juice daily to 146 participants against a control beverage in 143, for up to 18 months, in men and women at moderate coronary risk: no significant difference in overall intima-media thickness progression between groups, with less progression on juice confined to exploratory subgroup analyses Davidson 2009.
On blood pressure, the pooled picture holds up. Eight randomized trials pooled to a systolic reduction of 4.96 mmHg, 95% confidence interval −7.67 to −2.25, P < 0.001, and a diastolic reduction of 2.01 mmHg, −3.71 to −0.31, P = 0.021, with the systolic effect present regardless of trial duration or dose consumed Sahebkar 2017; a later synthesis reaches the same conclusion Ghaemi 2023, and the broader clinical literature on metabolic-syndrome risk factors is collected separately Laurindo 2022Basu 2009.
The specific obstacle is that the evidence is a beverage and the shelf sells a capsule. Every trial above used juice, at 50 mL Aviram 2001 or 240 mL Davidson 2009 a day. Juice carries punicalagins, ellagic acid, anthocyanins, potassium, organic acids and a substantial sugar load, all at once. A punicalagin-standardized extract carries one of those. Nobody has demonstrated that the extract reproduces the juice's blood-pressure effect, and the meta-analytic evidence is explicitly about juice Sahebkar 2017.
And the second obstacle is the one no trial has controlled for. If roughly a fifth of people are metabotype 0 and produce no urolithins at all Tomas-Barberan 2014, then every trial on this page averaged responders together with people in whom the proposed mechanism could not start. That dilutes a real effect toward the null in the positive trials and it may be part of why the intima-media thickness replication failed Davidson 2009. It is a testable explanation and nobody has tested it.
Pomegranate Extract — which form, and does it matter
Three products, three different bets. Juice is what the trials used Aviram 2001Aviram 2004Davidson 2009Sahebkar 2017, and it carries the whole matrix plus the sugar. A punicalagin- or ellagitannin-standardized extract is a concentrate of the precursor, betting that your gut will convert it. Urolithin A itself is now sold directly, which skips the conversion entirely and is the only one of the three that works in a metabotype 0 person Tomas-Barberan 2014.
What the standardization number means, and does not. A label declaring 40% punicalagins is declaring precursor content. A label declaring ellagic acid is declaring the hydrolysis product, which is one step further along and which the plant contains far less of than the marketing implies — most ellagic acid in a pomegranate is bound up in punicalagin. Neither number tells you anything about urolithin exposure, which is the only variable that matters, and which is not on any label because it is a property of you rather than of the product.
The site's card says standardized to punicalagins or ellagic acid, as directed, and that is where the honesty problem sits. As directed is not a dose, and there is no extract dose that has been shown to reproduce a juice trial. If you are buying this for blood pressure, the evidence-matched purchase is 240 mL of juice a day Davidson 2009Sahebkar 2017, with the sugar load accounted for in the rest of the diet.
Peel, aril and seed oil are three different plant parts. The ellagitannins are concentrated in the peel and the pith, which is why extract manufacturers use them and why extract chemistry is not juice chemistry. Pomegranate seed oil is a different product again, rich in punicic acid, with no ellagitannin claim at all.
What would have to be true, and how you would know it was not
1. Blood pressure, systolic (mmHg), seven-day home average — down about 5 mmHg at 8–12 weeks if you drink the juice. That is the pooled estimate and its confidence interval runs from about 2 to about 8 mmHg Sahebkar 2017. Predict the same reader on a punicalagin extract capsule gets less, because no trial has demonstrated the transfer, and treat that difference as the single most useful thing on this page.
2. The response should be bimodal, and that is the mechanism showing itself. Because urolithin production sorts people into three stable phenotypes rather than a smooth distribution Tomas-Barberan 2014, predict that a group of readers splits into clear responders and clear non-responders rather than spreading evenly. Practical consequence: a null result in one person is more likely to be their microbiome than the product, and the way around it is to take urolithin A directly rather than to raise the pomegranate dose.
3. The prediction that cuts against the product: carotid intima-media thickness will not measurably change in you. The three-year positive study is one of two on this endpoint Aviram 2004, and the larger, independently run replication found no significant difference in overall progression across 289 participants over 18 months Davidson 2009. On top of that, carotid ultrasound reproducibility between scans is of the same order as the yearly change being measured, so an individual scan pair cannot resolve it even if the effect is real. If a clinic offers you a before-and-after carotid scan to prove a supplement worked, that is a sales technique.
4. LDL Cholesterol, mg/dL — unchanged; oxidized LDL is the marker the mechanism actually predicts. The proposed action is on how LDL is oxidized and how ACE behaves Aviram 2001Aviram 2004, not on hepatic LDL production. Predict LDL-C flat at 12 weeks. If your laboratory offers oxidized LDL or paraoxonase-1 activity, those are the mechanistically correct numbers, and their absence from routine panels is the reason this product is hard to test properly.
What will fool you: replacing a daily soft drink with a daily pomegranate juice. Both the weight change and the sodium change that usually accompany that swap lower blood pressure on their own, and the cuff cannot tell them from the polyphenols.
What nobody has tested yet
Nobody has run a metabotype-stratified cardiovascular trial, and it is the most obviously missing study in this cohort. The stratifier is stable, cheap to assign from a urine sample after a single ellagitannin dose, and independent of age and health status Tomas-Barberan 2014. Phenotype 200 people, randomize within stratum, and read blood pressure at twelve weeks Sahebkar 2017. If the effect lives entirely in metabotypes A and B, this product needs a companion test and every trial to date has been diluting its own result.
Nobody has compared the extract with the juice. The entire clinical base is juice; the entire retail market is extract. A three-arm crossover — 240 mL juice, a punicalagin-matched extract, placebo — with plasma urolithin A and ambulatory blood pressure as endpoints would take twelve weeks and would tell every buyer on this shelf whether their purchase is supported.
Nobody has resolved the imaging discrepancy. One three-year positive trial Aviram 2004, one 18-month null Davidson 2009, and no third trial. Given that the two populations differed in baseline risk and the second was larger, a tie-breaker powered on carotid intima-media thickness progression and stratified by metabotype would be worth more than another dozen blood-pressure studies.
And nobody has related plasma urolithin A to blood pressure change. That is a straightforward addition to any future trial: one extra plasma sample, one liquid chromatography-mass spectrometry assay, and the field would finally have a dose-exposure-response relationship instead of a food.
Pomegranate Extract — its own safety story, not its category's
Punicalagin is a tannin, and tannins are hemostasis modulators. That is the specific, published version of the vague warning that polyphenols thin the blood Marcinczyk 2022. It matters most in a concentrated extract rather than in juice, because the extract is where the tannin load is, and it is additive with aspirin, with clopidogrel and with the fibrinolytic enzymes sold elsewhere in this same category.
Iron, which almost nobody flags and which is the interaction most likely to matter to a real reader. Condensed and hydrolysable tannins bind non-heme iron in the gut lumen and reduce its absorption. A vegetarian or a menstruating reader with a ferritin under 30 micrograms per liter who takes a high-tannin extract with meals is working against their own iron status. The fix is not to stop; it is to separate the extract from the iron-containing meal by two hours.
ACE-inhibitor additivity, with a real mechanism behind it. This is not a theoretical interaction: serum ACE activity fell 36% on juice Aviram 2001. Stacked on ramipril or perindopril, or on an angiotensin receptor blocker, the pharmacodynamic effect adds. The person who notices is the older reader who stands up from a chair, and the sensible precaution is to check standing blood pressure in the first fortnight rather than to avoid the combination.
The grapefruit question, answered rather than repeated. Pomegranate juice was investigated for a grapefruit-like inhibition of intestinal CYP3A4 after early in vitro signals, and the human studies have been largely reassuring — the effect that looked alarming in a test tube has not translated into the clinically important interactions grapefruit produces. This is a case where the scary claim did not hold up, and saying so is as useful as issuing another warning.
The sugar, stated plainly. A daily 240 mL glass of juice Davidson 2009 carries a sugar load comparable to a soft drink of the same size. For a reader with a fasting glucose above 100 mg/dL that is a real trade, and it is the specific reason the extract is attractive even though the extract is the form without the evidence.
And a boundary on high-tannin concentrates. Concentrated polyphenol extracts as a class have produced idiosyncratic liver injury — the green tea catechin story is the documented one. Nothing comparable has been established for pomegranate extract, and this is a reasoned extrapolation across a chemical class rather than a finding about this product. It is a reason to prefer the lowest effective dose of a concentrate, and to stop and get liver enzymes if nausea and dark urine appear.
Sources read for this page
- Aviram M, et al. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure.. Atherosclerosis 2001 · PMID 11500191
- Aviram M, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation.. Clinical Nutrition 2004 · PMID 15158307
- Davidson MH, et al. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.. American Journal of Cardiology 2009 · PMID 19766760
- Sahebkar A, et al. Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials.. Pharmacological Research 2017 · PMID 27888156
- Ghaemi F, et al. Impact of pomegranate juice on blood pressure: A systematic review and meta-analysis.. Phytotherapy Research 2023 · PMID 37461211
- Tomas-Barberan FA, et al. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status.. Journal of Agricultural and Food Chemistry 2014 · PMID 24976365
- Laurindo LF, et al. Pomegranate (Punica granatum L.) and Metabolic Syndrome Risk Factors and Outcomes: A Systematic Review of Clinical Studies.. Nutrients 2022 · PMID 35458227
- Basu A, et al. Pomegranate juice: a heart-healthy fruit juice.. Nutrition Reviews 2009 · PMID 19146506
- Marcinczyk N, et al. Tannins as Hemostasis Modulators.. Frontiers in Pharmacology 2022 · PMID 35095516
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Home blood pressure averaged across 7 days, before and after, because that is the endpoint its randomized trials report — the other one, endothelial function, is an ultrasound, and arterial plaque is a scan. There is nothing here you can feel, so an impression of benefit is not evidence of one.
- How long before it means anything: 8-12 weeks, with a caveat that matters more than the window does: only around 40% of people carry the gut bacteria that convert punicalagins to urolithin A efficiently, and no test on this menu tells you whether you are one of them. A null result may mean the mechanism never started in you rather than that the mechanism is wrong.
- What will fool you: Substituting the juice, which carries a large sugar load and pushes the metabolic numbers the other way. And if mitophagy was the reason you bought this, urolithin A can be bought directly and skips the conversion lottery entirely — that is precisely why those products exist.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Pomegranate Extract — safety & side effects
- Well tolerated; GI upset is the main report.
- Inhibits CYP3A4 like grapefruit — the same class of interaction, affecting statins, calcium channel blockers and others. Cases with warfarin and with statins have been reported.
- Lowers blood pressure — additive with antihypertensives.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Pomegranate Extract in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Pomegranate Extract
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| ApoB (Apolipoprotein B) | Counts the particles that cause plaque — a normal LDL-C can hide risk |
| Lipoprotein(a) — Lp(a) | Genetic, largely unmodifiable, and worth knowing once in your life |
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammatory half of cardiovascular risk |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | The standard baseline these are usually aimed at |
The Real Cardiovascular Risk panel covers these in one order — 9 markers, $187.60 with the discount applied.
Check results you already have → · All 103 markers A–Z
Pomegranate Extract — frequently asked questions
What is Pomegranate Extract?
A polyphenol extract for blood flow, blood pressure and antioxidant support — and the dietary source your gut turns into Urolithin A.
What is the suggested dose of Pomegranate Extract?
Standardized to punicalagins/ellagic acid, as directed. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Pomegranate Extract dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Pomegranate Extract?
Coach Cam sources Pomegranate Extract from vetted, top-rated brands on iHerb — use the buy link on this page.
What Pomegranate Extract is used for
Pomegranate Extract appears under 2 goals in the goal router.
Related Cardiovascular supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.